找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Evidence-biased Antidepressant Prescription; Overmedicalisation, Michael P. Hengartner Book 2022 The Editor(s) (if applicable) and The Aut

[復(fù)制鏈接]
樓主: mountebank
11#
發(fā)表于 2025-3-23 13:29:35 | 只看該作者
12#
發(fā)表于 2025-3-23 17:48:22 | 只看該作者
Flaws in Antidepressant Research,ed by the pharmaceutical industry to serve its commercial interests. The main objective is to outline the conduct and dissemination of antidepressant trials. The author details the multiple methodological limitations of these studies and further explains how study results are selectively reported an
13#
發(fā)表于 2025-3-23 21:47:13 | 只看該作者
Conflicts of Interest in Medicine,issal of harms resulting from medical interventions and the censoring and discrediting of experts questioning the benefit–harm ratio of established healthcare practices. A special emphasis is put on the denial and minimisation of both withdrawal syndromes resulting from physical dependence to antide
14#
發(fā)表于 2025-3-24 01:51:14 | 只看該作者
Solutions for Reform,prescribing of antidepressants in self-limiting, non-severe depression. It also makes suggestion as to how medical research, education, and practice can be freed from corporate bias, thus putting public health and patient safety over the commercial interests of the pharmaceutical industry.
15#
發(fā)表于 2025-3-24 03:21:56 | 只看該作者
16#
發(fā)表于 2025-3-24 09:46:41 | 只看該作者
17#
發(fā)表于 2025-3-24 14:42:02 | 只看該作者
978-3-030-82589-8The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerl
18#
發(fā)表于 2025-3-24 18:05:06 | 只看該作者
Environmental Business Channels,This chapter provides a short introduction into the themes of this book and the author’s career in psychiatric research. It details how and why the author started to study the efficacy and safety of antidepressants and the corruption of evidence-based medicine.
19#
發(fā)表于 2025-3-24 22:08:09 | 只看該作者
20#
發(fā)表于 2025-3-25 00:18:31 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-26 05:17
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
永胜县| 金坛市| 肃宁县| 商南县| 贵州省| 赤壁市| 临武县| 南丰县| 郎溪县| 安远县| 安国市| 达孜县| 芦山县| 防城港市| 巴东县| 磴口县| 班戈县| 大余县| 秦安县| 天镇县| 昭平县| 财经| 东山县| 奎屯市| 连江县| 内江市| 乌拉特前旗| 太和县| 两当县| 余江县| 商河县| 黎川县| 明溪县| 沭阳县| 池州市| 梅河口市| 阿巴嘎旗| 抚远县| 邮箱| 贺州市| 桐庐县|